Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A Boyd

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Biopharmaceutics & Drug Disposition|August 1, 1996
Characterization of a 7 day 17 beta-estradiol transdermal delivery system: pharmacokinetics in healthy postmenopausal womenR A Boyd, E A Zegarac, M A Eldon, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1987
Comparison of binding affinities and negative inotropic potencies of the 1,4-dihydropyridine calcium channel blockers in rabbit myocardiumR A Boyd, J C Giacomini, F M Wong, et al.
Clinical Pharmacology and Therapeutics|April 1, 1989
The pharmacokinetics of the enantiomers of atenololR A Boyd, S K Chin, O Don-Pedro, et al.
Obstetrics and Gynecology|October 1, 1996
Efficacy and local tolerance of a low-dose, 7-day matrix estradiol transdermal system in the treatment of menopausal vasomotor symptomsL Speroff, R W Whitcomb, N J Kempfert, et al.
Journal of Clinical Pharmacology|November 1, 1996
Pharmacokinetics of a 7-day 17 beta-estradiol transdermal delivery system: effect of application site and repeated applications on serum concentrations of estradiol and estroneR A Boyd, B B Yang, R B Abel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 1998
Anti-CD4 monoclonal antibody-induced tolerance to MHC-incompatible cardiac allografts maintained by CD4+ suppressor T cells that are not dependent upon IL-4B M Hall, L Fava, J Chen, et al.
Transplantation|May 29, 1998
The cellular basis of cardiac allograft rejection: VIII. Mechanisms underlying delayed allograft rejection in PVG C6-deficient ratsS Merten, J C Chen, H Ha, et al.
Clinical Pharmacology and Therapeutics|October 1, 1989
The pharmacokinetics and pharmacodynamics of diltiazem and its metabolites in healthy adults after a single oral doseR A Boyd, S K Chin, O Don-Pedro, et al.
Journal of Clinical Pharmacology|January 13, 2000
Atorvastatin coadministration may increase digoxin concentrations by inhibition of intestinal P-glycoprotein-mediated secretionR A Boyd, R H Stern, B H Stewart, et al.
Clinical Pharmacokinetics|June 8, 2000
Impact of population pharmacokinetic-pharmacodynamic analyses on the drug development process: experience at Parke-DavisS C Olson, H Bockbrader, R A Boyd, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Biopharmaceutics & Drug Disposition|August 1, 1996
Characterization of a 7 day 17 beta-estradiol transdermal delivery system: pharmacokinetics in healthy postmenopausal womenR A Boyd, E A Zegarac, M A Eldon, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1987
Comparison of binding affinities and negative inotropic potencies of the 1,4-dihydropyridine calcium channel blockers in rabbit myocardiumR A Boyd, J C Giacomini, F M Wong, et al.
Clinical Pharmacology and Therapeutics|April 1, 1989
The pharmacokinetics of the enantiomers of atenololR A Boyd, S K Chin, O Don-Pedro, et al.
Obstetrics and Gynecology|October 1, 1996
Efficacy and local tolerance of a low-dose, 7-day matrix estradiol transdermal system in the treatment of menopausal vasomotor symptomsL Speroff, R W Whitcomb, N J Kempfert, et al.
Journal of Clinical Pharmacology|November 1, 1996
Pharmacokinetics of a 7-day 17 beta-estradiol transdermal delivery system: effect of application site and repeated applications on serum concentrations of estradiol and estroneR A Boyd, B B Yang, R B Abel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 1998
Anti-CD4 monoclonal antibody-induced tolerance to MHC-incompatible cardiac allografts maintained by CD4+ suppressor T cells that are not dependent upon IL-4B M Hall, L Fava, J Chen, et al.
Transplantation|May 29, 1998
The cellular basis of cardiac allograft rejection: VIII. Mechanisms underlying delayed allograft rejection in PVG C6-deficient ratsS Merten, J C Chen, H Ha, et al.
Clinical Pharmacology and Therapeutics|October 1, 1989
The pharmacokinetics and pharmacodynamics of diltiazem and its metabolites in healthy adults after a single oral doseR A Boyd, S K Chin, O Don-Pedro, et al.
Journal of Clinical Pharmacology|January 13, 2000
Atorvastatin coadministration may increase digoxin concentrations by inhibition of intestinal P-glycoprotein-mediated secretionR A Boyd, R H Stern, B H Stewart, et al.
Clinical Pharmacokinetics|June 8, 2000
Impact of population pharmacokinetic-pharmacodynamic analyses on the drug development process: experience at Parke-DavisS C Olson, H Bockbrader, R A Boyd, et al.
Pageof 4